Megan R. Baca

Associate

baca-megan-r
  • JD, Harvard Law School, 2007
  • MA (Sociology), Stanford University, 2004
  • BS (Science, Technology & Society: Computer Science), Stanford University, 2004

Bar Admissions

  • California, 2012
  • Massachusetts, 2007
  • Speaker at various Boston Bar Association intellectual property events.

Megan R. Baca

Associate

Megan advises a wide range of public and private companies, investors, and universities in a variety of transactions involving corporate and intellectual property matters, including technology licensing and transfer, product development collaborations, joint ventures, mergers and acquisitions, supply arrangements, distribution and co-promotion arrangements, outsourcing transactions, and other strategic commercial agreements. Megan also represents venture-backed companies in financings and ongoing matters.

Megan works with companies in a broad range of industries including technology, software, branded products, media, pharmaceutical, biotechnology, medical device, and finance.

Experience

  • Represented Ironwood Pharmaceuticals in developing and implementing its worldwide licensing strategy for linaclotide, including licensing linaclotide to Forest Laboratories, Laboratorios Almirall and Astellas Pharma with aggregate upfront payments of $140 million.
  • Represented Genzyme Corporation in connection with its divestiture of three non-core business units, including the sale of its Genzyme Genetics business unit to Laboratory Corporation of America for $925 million
  • Represented Pfizer in connection with the outsourcing of its post-proof of concept clinical trial management function to Parexel International, Inc. and Icon Clinical Research Limited.
  • Represented Zynga in its acquisition of various online gaming companies.
  • Represented a major pharmacy benefits manager in renegotiation of a troubled, mission-critical IT outsourcing relationship and subsequent RFP for and negotiation of a successful replacement IT outsourcing relationship.
  • Represented a luxury product company in the strategic commercialization of its IP assets and portfolio structuring.
  • Represented an advertising agency on corporate and commercial matters, including legal review and clearance of advertising material.

Insights

Publications

  • Co-author, “Right of Publicity Laws: Massachusetts,” Practical Law Company (March 2012)

West Coast Lunchtime Legal Briefing - Social Media Enforcement: FDA, FTC, and National Advertising Division Case Studies and Practical Advice for Handling an Investigation or Enforcement Action

As social media becomes an increasingly important marketing strategy for consumer-facing companies, including technology, life sciences, media, entertainment, and consumer products companies, the Food and Drug Administration (FDA), Federal Trade Commission (FTC), and National Advertising Division of the Better ...

View all events